In contrast, the downregulation of regulator of G‐protein signaling 2 (RGS2) was observed in CRC tissues with recurrence and in metastasis‐derived cell lines, and its low levels correlated with poor patient survival [37]. This evidence concerns the gene RGS2 and colorectal carcinoma.